Bcl-2 and Β 1-integrin predict survival in a tissue microarray of small cell lung cancer

British Journal of Cancer

Volumn 103, Issue 11, 2010, Pages 1710-1715

  Lawson, M H ^a,b,c   Cummings, N M ^b   Rassl, D M ^b   Vowler, S L ^a   Wickens, M ^a   Howat, W J ^a   Brenton, J D ^a,c   Murphy, G ^a,c   Rintoul, R C ^b  

^a CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

1 integrin; Bcl 2; small cell lung cancer; tissue microarray

Indexed keywords

ANTINEOPLASTIC AGENT; BETA1 INTEGRIN; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HAZARD RATIO; HUMAN; HUMAN TISSUE; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SYSTEMATIC REVIEW; TISSUE MICROARRAY;

AGED; ANTIGENS, CD29; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-BCL-2; SMALL CELL LUNG CARCINOMA; TISSUE ARRAY ANALYSIS;

EID: 78650201529     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605950     Document Type: Article

References (34)

1. Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11: 155-168
2. Amarasena IU, Walters JA, Wood-Baker R, Fong K (2008) Platinum versus non-platinum chemotherapy regimens for small cell lung cancer. Cochrane Database Syst Rev 2008; (4): CD006849
3. Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH, Minna JD (1985) Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 45: 2913-2923
4. Chiappori AA, Zheng Z, Chen T, Rawal B, Schell MJ, Mullaney BP, Bepler G (2010) Features of potentially predictive biomarkers of chemotherapeutic efficacy in small cell lung cancer. J Thorac Oncol 5: 484-490
5. Coghlin CL, Smith LJ, Bakar S, Stewart KN, Devereux GS, Nicolson MC, Kerr KM (2010) Quantitative analysis of tumor in bronchial biopsy specimens. J Thorac Oncol 5: 448-452
6. Dingemans AM, Witlox MA, Stallaert RA, van der Valk P, Postmus PE, Giaccone G (1999) Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer. Clin Cancer Res 5: 2048-2058
7. Donati V, Faviana P, Dell'omodarme M, Prati MC, Camacci T, De Ieso K, Giannini R, Lucchi M, Mussi A, Pingitore R, Basolo F, Fontanini G (2004) Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer. Hum Pathol 35: 1347-1352
8. El-Helw LM, Rogers TK, Hatton MQ (2008) Small-cell lung cancer: 8 years experience of a single multidisciplinary team. J Oncol 2008: 150760
9. Hann CL, Daniel VC, Sugar EA, Dobromilskaya I, Murphy SC, Cope L, Lin X, Hierman JS, Wilburn DL, Watkins DN, Rudin CM (2008) Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer. Cancer Res 68: 2321-2328
10. Hann CL, Rudin CM (2007) Fast, hungry and unstable: finding the Achilles' heel of small-cell lung cancer. Trends Mol Med 13: 150-157
11. Hassan S, Ferrario C, Mamo A, Basik M (2008) Tissue microarrays: emerging standard for biomarker validation. Curr Opin Biotechnol 19: 19-25
12. Huisman C, Postmus PE, Giaccone G, Smit EF (1999) Second-line chemotherapy and its evaluation in small cell lung cancer. Cancer Treat Rev 25: 199-206
13. Ilievska Poposka B, Smickova S, Jovanovska Crvenkovska S, Zafirovska Ivanovska B, Stefanovski T, Petrusevska G (2008) Bcl-2 as a prognostic factor for survival in small-cell lung cancer. Prilozi 29: 281-294
14. Kaiser U, Schilli M, Haag U, Neumann K, Kreipe H, Kogan E, Havemann K (1996) Expression of bcl-2-protein in small cell lung cancer. Lung Cancer 15: 31-40
15. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847
16. Lee HW, Han JH, Kim JH, Lee MH, Jeong SH, Kang SY, Choi JH, Oh YT, Park KJ, Hwang SC, Sheen SS, Lim HY (2008) Expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with small cell lung cancer. Lung Cancer 59: 95-104
17. Lumley T (2009) rmeta: Meta-analysis: R package. http://CRAN.R-project. org/package/rmeta
18. Maitra A, Amirkhan RH, Saboorian MH, Frawley WH, Ashfaq R (1999) Survival in small cell lung carcinoma is independent of Bcl-2 expression. Hum Pathol 30: 712-717
19. Martin B, Paesmans M, Berghmans T, Branle F, Ghisdal L, Mascaux C, Meert AP, Steels E, Vallot F, Verdebout JM, Lafitte JJ, Sculier JP (2003) Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 89: 55-64
20. Nitadori J, Ishii G, Tsuta K, Yokose T, Murata Y, Kodama T, Nagai K, Kato H, Ochiai A (2006) Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel. Am J Clin Pathol 125: 682-692
21. Oshita F, Kameda Y, Ikehara M, Tanaka G, Yamada K, Nomura I, Noda K, Shotsu A, Fujita A, Arai H, Ito H, Nakayama H, Mitsuda A (2002) Increased expression of integrin beta1 is a poor prognostic factor in small-cell lung cancer. Anticancer Res 22: 1065-1070
22. Paik KH, Park YH, Ryoo BY, Yang SH, Lee JC, Kim CH, Ki SS, Kim JM, Park MJ, Ahn HJ, Choi W, Chung JH (2006) Prognostic value of immunohistochemical staining of p53, bcl-2, and Ki-67 in small cell lung cancer. J Korean Med Sci 21: 35-39
23. Pardo OE, Arcaro A, Salerno G, Raguz S, Downward J, Seckl MJ (2002) Fibroblast growth factor-2 induces translational regulation of Bcl-XL and Bcl-2 via a MEK-dependent pathway: correlation with resistance to etoposide-induced apoptosis. J Biol Chem 277: 12040-12046
24. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17: 2815-2834
25. Rudin CM, Salgia R, Wang X, Hodgson LD, Masters GA, Green M, Vokes EE (2008) Randomized phase II study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103. J Clin Oncol 26: 870-876
26. Sartorius UA, Krammer PH (2002) Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines. Int J Cancer 97: 584-592
27. Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C, Chilvers ER, Dransfield I, Donnelly SC, Strieter R, Haslett C (1999) Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 5: 662-668
28. Shanghai Outdo Biotech Ltd. Human Tissue Array OD-CT-RsLug01-003. http://www.superchip.com.cn/Upload/UploadFile/pdf/OD-CT-RsLug01-003.pdf
29. Shoemaker AR, Mitten MJ, Adickes J, Ackler S, Refici M, Ferguson D, Oleksijew A, O'Connor JM, Wang B, Frost DJ, Bauch J, Marsh K, Tahir SK, Yang X, Tse C, Fesik SW, Rosenberg SH, Elmore SW (2008) Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models. Clin Cancer Res 14: 3268-3277
30. Takayama K, Ogata K, Nakanishi Y, Yatsunami J, Kawasaki M, Hara N (1996) Bcl-2 expression as a predictor of chemosensitivities and survival in small cell lung cancer. Cancer J Sci Am 2: 212-216
31. Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501
32. Yao ES, Zhang H, Chen YY, Lee B, Chew K, Moore D, Park C (2007) Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res 67: 659-664
33. Zereu M, Vinholes JJ, Zettler CG (2003) p53 and Bcl-2 protein expression and its relationship with prognosis in small-cell lung cancer. Clin Lung Cancer 4: 298-302
34. Zhang Z, Vuori K, Reed JC, Ruoslahti E (1995) The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci USA 92: 6161-6165